IMVT- Immunovant, Inc.

Name: Immunovant, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunovant, Inc. (IMVT) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Venker Eric	1.30M	$50.51M	-
CFO	Girao Tiago	247.6K	$9.62M	-10,000
COO	Gloria Melanie	224.4K	$8.72M	-17,714
Other	Stout Jay S	218.4K	$8.49M	-40,000
Other	Geffner Michael	218.0K	$8.47M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 22, 2024	Salzmann Peter51	Chief Executive Officer	Sell	13,454	$36.15	$486,362.10	-1.4%	-17.9%	-40.9%
Jan 26, 2024	Levine Mark S.66	Chief Legal Officer	Sell	3,027	$37.92	$114,778.41	-0.5%	-27.5%	-39.7%
Jan 26, 2024	Geffner Michael66	Chief Medical Officer	Sell	10,101	$37.92	$383,011.53	-5.3%	-27.5%	-39.7%
Jan 18, 2024	MacIas William L.51	Chief Medical Officer	Sell	424	$41.03	$17,396.72	-0.1%	-29.9%	-41.1%
Jan 11, 2024	Barnett Eva Renee58	Chief Financial Officer	Sell	3,515	$41.83	$147,023.46	-0.5%	-28.0%	-45.2%
Jan 5, 2024	Butchko Julia G.46	Chief Development Officer	Sell	1,297	$38.59	$50,051.23	-0.3%	-27.9%	-42.0%
Jan 5, 2024	Salzmann Peter51	Chief Executive Officer	Sell	3,824	$38.59	$147,568.16	-0.4%	-27.9%	-42.0%
Dec 1, 2023	Migausky George V	Director	Sell	12,700	$39.73	$504,567.30	-3.6%	-12.8%	-30.5%
Dec 1, 2023	Pande Atul74	Director	Sell	12,350	$39.73	$490,667.50	-4.5%	-12.8%	-30.5%
Dec 1, 2023	Fromkin Andrew J.45	Director	Sell	12,350	$39.73	$490,696.72	-4.2%	-12.8%	-30.5%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC